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ABSTRACT 13 
KCC2, encoded in humans by the SLC12A5 gene, is a multifunctional neuron-specific protein initially 14 
identified as the chloride (Cl-) extruder critical for hyperpolarizing GABAA receptor currents. Independently 15 
of its canonical function as a K-Cl cotransporter, KCC2 regulates the actin cytoskeleton via molecular 16 
interactions mediated through its large intracellular C-terminal domain (CTD). Contrary to the common 17 
assumption that embryonic neocortical projection neurons express KCC2 at non-significant levels, here we 18 
show that loss of KCC2 enhances apoptosis of late-born upper layer cortical projection neurons. In utero 19 
electroporation of plasmids encoding truncated, transport-dead KCC2 constructs retaining the CTD were as 20 
efficient as those encoding full-length KCC2 in preventing elimination of migrating projection neurons upon 21 
conditional deletion of KCC2. This was in contrast to the effect of a full-length KCC2 construct bearing a CTD 22 
missense mutation (KCC2R952H), which disrupts cytoskeletal interactions and has been found in patients with 23 
neurological and psychiatric disorders, notably seizures and epilepsy. Together, our findings indicate an ion-24 
transport independent, CTD-mediated regulation of developmental apoptosis by KCC2 in migrating cortical 25 
projection neurons. 26 
Keywords: cell death, migration, GABA, chloride, cofilin, KCC2  27 
INTRODUCTION 28 
During early cortical development, neurons are generated in excess, and a substantial portion of them 29 
undergo apoptosis, a process crucial for the establishment of the final number of neurons and the 30 
organization of cerebrocortical networks [1–3]. In the mouse neocortex, the first wave of apoptosis affects 31 
neural progenitors and early post-mitotic neurons during embryonic development, with a peak around 32 
embryonic day (E) 14 [3–5]. This roughly corresponds to the first apoptotic wave in humans from the 33 
postconceptional week (PCW) 6.5 up until the end of the first trimester of gestation [6,7]. The second peak 34 
in developmental neuroapoptosis is activity-dependent and takes place during the first postnatal week in 35 
the mouse, this time affecting newly differentiated neurons [8–10]. Ultimately, up to 40% of cortical 36 
neurons are eliminated by developmental apoptosis [11,12]. Some neuronal populations, like the Cajal-37 
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Retzius neurons (CRNs), disappear almost entirely during the second wave of apoptosis [13,14]. Contrary to 38 
the overall cortical neuronal population, CRNs do not show developmental up-regulation of the neuronal K-39 
Cl cotransporter KCC2, but persistently express the Cl- importer NKCC1, resulting in excitation of CRNs by 40 
GABAA receptors (GABAARs) [15,16]. Interestingly, reduction of intracellular Cl
- by genetic deletion of NKCC1 41 
or its inhibition with bumetanide exerts a pro-survival effect on these cells in vitro [17].  42 
 GABAAR activation during embryonic development elicits depolarizing or even excitatory actions on CNS 43 
neurons, which play an important role in neuronal proliferation, migration, and synaptogenesis [18,19]. The 44 
developmental increase in Cl- extrusion mediated by KCC2 sets the low intraneuronal Cl- concentration 45 
needed for hyperpolarizing GABAAR-mediated signaling in most mature central neurons [20,21]. At the time 46 
of the first apoptotic wave, synaptic coupling of cortical neurons is however relatively weak [22–24], and 47 
neuroapoptosis at this early stage is likely to be independent of neuronal activity.  48 
Genetic ablation of KCC2 in mature hippocampal pyramidal neurons has been reported to decrease their 49 
survival [25,26]. In contrast, ablation of KCC2 in migrating cortical interneurons did not alter their rate of 50 
apoptosis, despite early expression of KCC2 in this type of neuron [27]. Contrary to the widespread 51 
assumption that KCC2 is expressed at a non-significant level in perinatal mouse and rat cortical pyramidal 52 
neurons, we recently found that KCC2-mediated Cl- extrusion in hippocampal CA3 pyramidal neurons exerts 53 
significant control over spontaneous network events already at this early stage in development [28]. It is, 54 
however, unknown what role KCC2 may play in migrating neocortical projection neurons (PNs) in which 55 
KCC2, upon overexpression, appears to be kinetically inactivated as an ion transporter until around birth in 56 
altricial rodents [29,30].  57 
Independently of its canonical K-Cl cotransport function, KCC2 also regulates the actin cytoskeleton in 58 
dendritic spines via interactions mediated by its C-terminal domain (CTD) [31–35]. This is in part achieved 59 
by modulating the phosphorylation of cofilin, one of the major actin-regulating proteins [36,37]. KCC2 60 
mutations found in patients with neurodevelopmental disorders [38–40] may disrupt both ion transport-61 
dependent and transport-independent functions of KCC2, prompting the idea that alterations in KCC2 62 
expression unrelated to chloride regulation may have clinically important consequences on neuronal 63 
development [38].  64 
Here we show using constitutive and conditional knockout models that loss of the non-canonical ion 65 
transport-independent functions of KCC2 in late-born upper layer cortical projection neurons promotes 66 
their developmental apoptosis in vivo. Our data indicate that signalling mediated by the KCC2 CTD is 67 
involved in the timely elimination of projection neurons during neurogenesis.  68 
 69 
RESULTS AND DISCUSSION 70 
Genetic loss of KCC2 promotes apoptosis of embryonic neocortical projection neurons in vivo 71 
In contrast to the well-characterized postnatal up-regulation of KCC2 in neocortical PNs of mice and rats 72 
[20,35,41–44], little information is available on expression patterns of KCC2 in perinatal, migrating 73 
neocortical PNs. To explore the temporal expression of KCC2 in embryonic mouse neocortical PNs, we used 74 
the Developing Cortical Neuron Transcriptome RNA-seq resource ([45];Data ref: [46]). In line with previous 75 
work on the expression levels of KCC2 protein in E15.5 mouse cortex [47], mRNA encoding KCC2 (Slc12a5) 76 
was expressed at a detectable level (FPKM ≥ 2; [45]; Data ref: [46]) on E15.5, E16.5 and E18.5 in subcerebral 77 
(FPKM, E15.5: 3.4 ± 1.1; E16.5: 8.0 ± 2.3; E18.5: 18.5 ± 4.8), corticothalamic (FPKM, E15.5: 5.1 ± 1.7; E16.5: 78 
7.5 ± 2.1; E18.5: 19.4 ± 5.3), and callosal PNs (FPKM, E15.5: 2.9 ± 1.0; E16.5: 2.3 ± 0.8; E18.5: 9.6 ± 2.8) (Fig 79 
EV1).  80 
We next explored whether and how the deletion of endogenous KCC2 may affect the development of 81 
immature pyramidal neurons in the embryonic mouse cortex. To this end, we generated a Kcc2lox/lox mouse, 82 
in which exon-5 is flanked by loxP sites. Deleting exon-5 results in a frameshift and a preterm stop codon, 83 
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thus abolishing KCC2 expression (Fig EV2A). Successful deletion of this exon upon expression of Cre-84 
recombinase (Cre) was verified by crossing these mice with E2a-CRE deleter mice (Fig EV2B), or by 85 
transfecting primary cortical neurons with Cre (Fig EV2C).  86 
To follow KCC2 expression at E18.5 in PNs migrating to the upper cortical layers, we used in utero 87 
electroporation (IUE) of an EGFP construct in Kcc2lox/lox embryos at E14.5. At this age, IUE targets neural 88 
progenitors that give rise to the initial migratory wave of layer II/III PNs and to the last wave of layer IV 89 
upper cortical PNs [48].  IUE was carried out using the classical 0° electrode paddle orientation [49], which 90 
enables selective targeting of PNs with no effect on interneuronal progenitors [50,51]. KCC2 91 
immunostaining using an anti-KCC2 antibody validated in E18.5 Kcc2–/– cortical sections [28], revealed that 92 
a fraction (14.5 ± 1.2%) of EGFP+ neurons in the cortical plate had somatic, plasmalemmal-like KCC2 93 
immunoreactivity (Fig EV2D and E). The fraction of neurons with such an immunosignal at E18.5 among the 94 
upper cortical PNs labeled with IUE of EGFP at 14.5 observed presently is close to the 13-30% reported for 95 
hippocampal CA3 pyramidal neurons at this age [28,52]. These are, however, likely to be underestimates as 96 
a substantial part of the total KCC2 pool may be contained in transport vesicles [52–54], where the CTD of 97 
KCC2 is facing the cytosol and free to interact with its targets.  98 
To delete KCC2 from a sub-population of PNs destined for upper cortical layers, we employed IUE of 99 
plasmids expressing Cre and a fluorescent marker (EGFP or RFP) in Kcc2lox/lox embryos. The efficacy of Cre-100 
mediated ablation of KCC2 in Kcc2lox/lox animals at E18.5 was confirmed using KCC2 immunostaining, which 101 
showed that 0.3 ± 0.1% of the neurons co-electroporated with EGFP and Cre (EGFP+Cre) were KCC2+ (Fig 102 
EV2D and E). Analysis of Cre immunostaining showed co-expression of Cre in the vast majority of EGFP+ 103 
neurons (Fig EV2F and G), in line with our previous results on the high level of co-expression of plasmid 104 
constructs following co-electroporation in utero [34].  105 
Previous studies reported no effect of KCC2 overexpression in layer II-IV PN progenitors on the 106 
distribution (reflecting both proliferation and migration) of the derived PNs in the embryonic cortex 107 
[29,55]. Given that genetic ablation of KCC2 in mature hippocampal pyramidal neurons has been reported 108 
to decrease their survival [25,26], we compared the number of EGFP+ neurons/region of interest (ROI) at 109 
E18.5 in slices prepared from embryos co-electroporated with EGFP+Cre to the controls electroporated 110 
with EGFP alone at E14.5. A significantly fewer number of neurons was observed in Kcc2lox/lox embryos co-111 
electroporated with Cre (-57.4 ± 6.7% to EGFP; Fig 1A and B). The number of neurons co-electroporated 112 
with Cre and a plasmid encoding full-length KCC2 (KCC2FL; [31,34,44]) was not different from control (-3.59 113 
± 9.9% to EGFP; Fig 1A and B), indicating that the Cre-induced decrease in the number of EGFP+ Kcc2lox/lox 114 
neurons could be prevented by compensating for the loss of endogenous KCC2. The same effect of Cre was 115 
observed when EGFP was replaced with mRFP (-45.5 ± 9.1% to mRFP; Fig EV3A and B). No significant 116 
difference was observed either in the number of EGFP or RFP transfected neurons with (+10.5 ± 13.5% to 117 
EGFP, p = 0.70) or without Cre (+23.9 ± 20.6%, p = 0.70, one-way ANOVA, with Holm-Sidak’s post hoc; data 118 
not illustrated).  119 
To test the hypothesis that the Cre-dependent decrease in the number of electroporated Kcc2lox/lox 120 
neurons is due to increased apoptosis, we performed TUNEL staining and cleaved Caspase-3 (Cas3) 121 
immunostaining at E16.5 of slices from EGFP+Cre electroporated embryos. Significantly higher fractions of 122 
TUNEL+ and Cas3+ neurons were found among embryos with EGFP+Cre compared to EGFP alone (Cas3, 123 
EGFP: 0.1 ± 0.1%; EGFP+Cre: 6.7 ± 0.2%; TUNEL, EGFP: 4.3 ± 0.7%; EGFP+Cre: 15.4 ± 2%; Fig 1C and D), 124 
indicating that the decrease in neuronal number observed two days later is caused by increased apoptosis 125 
following loss of KCC2. At E16.5, no significant difference in the number of EGFP+ neurons was observed 126 
between the two electroporation conditions (EGFP+Cre: +2.4 ± 7.1% to EGFP, Fig 1E), suggesting that 127 
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decreased proliferation of neural progenitors is unlikely to contribute to the decrease in the number of 128 
neurons at E18.5.  129 
To examine possible effects of KCC2 deletion on neuronal maturation, we performed whole-cell patch 130 
clamp recordings from Cre+EGFP-cotransfected (Kcc2lox/lox(+Cre)) and neighboring non-transfected 131 
(Kcc2lox/lox(-Cre)) pyramidal shaped-neurons in somatosensory cortical slices at postnatal day 15-17 Kcc2lox/lox. 132 
In line with the efficacy of Cre-mediated ablation of KCC2 in Kcc2lox/lox animals at E18.5, net Cl- extrusion 133 
measured under conditions of constant somatic Cl- load [44,56] of Cre-transfected neurons was abolished, 134 
shifting EGABA close to the level dictated by the Cl
- concentration of the pipette both at the soma (mean 135 
EGABA, Kcc2
lox/lox(-Cre): -56.4 ± 1.4 mV; Kcc2lox/lox(+Cre): -48.5 ± 0.8 mV) and at a distance of 50 µm in a dendritic 136 
location (mean EGABA, Kcc2
lox/lox(-Cre): -66.2 ± 1.6 mV; Kcc2lox/lox(+Cre): -51.3 ± 1.7 mV; Fig EV4A and B). However, 137 
no differences were observed (cf. [57]) in basic electrophysiological parameters, including resting 138 
membrane potential, input resistance or membrane capacitance (Fig EV4C-E), the latter used as a proxy for 139 
plasmalemmal membrane surface area and, thus, dendritic arbor complexity [26,36].  140 
Taken together, these data indicate that cell-specific loss of KCC2 increases apoptotic cell death of late-141 
born PNs destined for upper cortical layers, without perturbing proliferation or affecting the maturation of 142 
the above electrophysiological parameters, apart from EGABA.  143 
 144 
Ion transport-independent action of KCC2 CTD promotes the survival of migrating projection neurons  145 
To investigate whether the ability of KCC2FL to prevent the observed decrease in the number of neurons is 146 
due to the ion transport-independent role of KCC2, we examined the effects of two ion transport-dead 147 
KCC2 constructs. An N-terminally truncated KCC2 construct, which comprises the transmembrane and C-148 
terminal domains (KCC2ΔNTD, Fig 2A, lower panel), or another construct, which comprises the entire CTD 149 
alone (KCC2CTD, Fig 2A, lower panel) [31,34,38] were co-electroporated with Cre at E14.5 and transfected 150 
neurons were counted at E18.5 as for KCC2FL. No significant difference was observed between 151 
Cre+KCC2ΔNTD or Cre+KCC2CTD when compared to Cre+KCC2FL (Cre+KCC2ΔNTD: +6.0 ± 5.7% to Cre+KCC2FL; 152 
Cre+KCC2CTD: -12.6 ± 6.2% to Cre+KCC2FL; Fig 2A and B). These data indicate that the mere CTD of KCC2 is as 153 
efficient as full-length KCC2 in preventing the loss of neurons triggered by KCC2 ablation (Fig 2B).  154 
We next electroporated Cre+KCC2R952H, a full-length disease-variant of KCC2, carrying an arginine-to-155 
histidine substitution in its distal CTD (Fig 2A, lower panel) found in patients with seizures and 156 
neurodevelopmental disorders [38–40]. KCC2R952H, upon overexpression in neocortical PNs, was previously 157 
found to confer reduced Cl- extrusion and completely lack the ion transport-independent capacity to 158 
promote dendritic spinogenesis, indicating that this missense point mutation disrupts cytoskeletal 159 
interactions mediated by KCC2 CTD [38]. Indeed, unlike the situation with Cre+KCC2ΔNTD and Cre+KCC2CTD, a 160 
significant difference in the number of neurons was observed when Cre+KCC2R952H was compared to 161 
Cre+KCC2FL (Cre+KCC2R952H: -41.6 ± 3.1% to Cre+KCC2FL; Fig 2A and B). 162 
KCC2, via molecular interactions downstream of its CTD, controls actin dynamics in dendritic spines by 163 
regulating cofilin phosphorylation [36,37], with constitutive loss of KCC2 expression resulting in cofilin 164 
hyperphosphorylation in mouse cortical neurons [36]. Cofilin, a major actin-regulating protein, has been 165 
implicated in apoptosis of cortical primary neurons [58]. To study the possible cellular mechanism 166 
downstream of KCC2 CTD action, we tested whether the apoptotic process triggered by loss of KCC2 could 167 
be prevented by compensating for cofilin hyperphosphorylation. Indeed, electroporation of Cre together 168 
with a plasmid encoding a non-phosphorylatable cofilin mutant, cofilinS3A [59], was as efficient as co-169 
electroporation of Cre+KCC2FL in preventing the loss of PNs upon deletion of endogenous KCC2 expression 170 
(Cre+cofilinS3A: -6.2 ± 8.9% to Cre+KCC2FL; Fig 2A and B).  171 
In sum, the above data strongly support the idea that the observed increase in apoptosis of embryonic 172 
cortical projection neurons is due to the loss of ion transport-independent actions mediated by KCC2 173 
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through its intracellular CTD. Our data strongly support the idea that the regulatory function of KCC2 in 174 
developmental apoptosis does not necessitate its plasmalemmal expression. A key observation here is that 175 
plasmids encoding transport-dead KCC2 constructs (KCC2CTD, KCC2ΔNTD) were as efficient in preventing 176 
neuronal loss as full-length KCC2. N-terminal truncation of KCC2 [31,38] results in complete loss of its K-Cl 177 
cotransport activity. It has been suggested that this may interfere with its delivery to the plasma membrane 178 
[60]. However, data obtained in neurons in vivo demonstrate that plasmalemmal expression of KCC2 may 179 
not be necessary for ion transport-independent functions mediated by the CTD, as indeed shown in the 180 
context of spinogenesis [34]. This also appears to be the case presently, as neuronal survival following KCC2 181 
deletion was rescued by the N-terminally truncated KCC2ΔNTD as well as KCC2CTD, the latter lacking not only 182 
the N-terminal domain but also the transmembrane domains necessary for membrane expression.  183 
 184 
Cell death mediated by KCC2 deletion differentially affects upper cortical PNs migrating in deep vs. 185 
superficial layers at E18.5 186 
Birth-dating experiments using BrdU and IUE indicate that mouse upper cortical PNs labeled at E14.5 187 
comprise of neurons belonging to both layers II/III and IV [48,61]. Cortical PNs born at E14.5 are still 188 
migrating at E18.5 [48]. Since only a fraction of the total number of Cre-electroporated Kcc2lox/lox neurons 189 
underwent apoptosis, we analyzed the number of the neurons that survived by E18.5 with regard to their 190 
distribution within and outside their migratory target-region, demarcated by the upper boundary of the 191 
layer V-specific marker Ctip2. We found that the significant decrease in the number of EGFP+Cre neurons 192 
was accounted by those located below the upper boundary of layer V, i.e. in the lower cortical regions and 193 
below the cortical plate (EGFP+Cre: -77.1 ± 4.5% to EGFP; Fig 3A and B). No significant difference in the 194 
number of neurons that had already migrated into the upper cortical plate by E18.5 was observed 195 
(EGFP+Cre: -14.13 ± 12.5% to EGFP; Fig 3A and B). A qualitatively similar effect of Cre was observed when 196 
EGFP was replaced with mRFP, with a significantly lower number of Cre+mRFP+ neurons below the upper 197 
boundary of the layer V-specific marker Ctip2 (mRFP+Cre: -74.4 ± 5.8% to mRFP; Fig 3C and D), but not 198 
above it (mRFP+Cre: -17.2 ± 11.8% to mRFP; Fig 3C and D). These findings suggest that among the 199 
population of progenitors targeted at E14.5, the increase in apoptosis is preferential to those yielding later 200 
migrating neurons destined for the superficial parts of the upper cortical layers II-IV [48] and thus are more 201 
likely to represent layer II/III neurons.  202 
Interestingly, co-electroporation of Cre+KCC2R952H resulted in a statistically significant decrease in the 203 
number of neurons that had migrated at E18.5 to the upper cortical layers (Cre+KCC2R952H: -33.2 ± 5.9% to 204 
Cre; Fig 3E and F). In full accordance with the inability of this mutant to promote survival (Fig 2B), no 205 
significant increase compared to the Cre-alone condition was observed in the number of Cre+KCC2R952H 206 
neurons that were still migrating towards the upper cortical plate (Cre+KCC2R952H: +44.8 ± 12.5% to Cre; Fig 207 
3E and F). In contrast, Cre+KCC2FL and Cre+KCC2CTD both showed a significantly higher number of neurons in 208 
this region (Cre+KCC2FL: +337 ± 41.5% to Cre; Cre+KCC2CTD: +214.4 ± 16.5% to Cre; Fig 3E and F). These 209 
findings indicate that the impact of KCC2R952H differs radically from that of full KCC2 deletion, affecting 210 
neurons that at E18.5 are migrating as well as those that have already reached the upper cortical layers by 211 
that time. This point mutation in the CTD has been previously shown to compromise neuronal Cl- extrusion 212 
capacity, and it entirely abolishes the interactions of the KCC2 CTD with the actin cytoskeleton in dendritic 213 
spines [38,39]. A possible explanation of the qualitative difference in action of KCC2 deletion and this C-214 
terminal mutation might be in their differential effect on targets downstream of the KCC2 CTD, which 215 
notably includes cofilin [36,37]. Indeed, we observed presently (see above) that neuronal loss was 216 




Constitutive ablation of KCC2 does not alter cortical lamination but increases cell death of deep-layer 219 
migrating upper cortical layer PNs at E18.5  220 
In light of the observed KCC2 loss-induced preferential decrease in the number of PNs still migrating at 221 
E18.5 (Fig 3A), which have not yet contributed to the cortical layers present at this stage of development, 222 
we examined whether constitutive ablation of KCC2 affects the number of neurons labeled with cortical 223 
layer-specific markers within the layers present at E18.5. To this end, we employed constitutive Kcc2–/– 224 
mouse embryos [62]. Quantitative analysis of brain sections showed that the laminar organization of the 225 
Kcc2–/– embryonic cortex at E18.5 was similar to that of their Kcc2+/+ littermates, as seen by immunolabeling 226 
using cortical layer-specific markers in coronal slices from closely matched bregma regions of the 227 
developing neocortex (Fig 4). We used Cux1 to mark the late-born neurons of layers II-IV [63], Ctip2 to mark 228 
layer V neurons [64], and Tbr1 to mark early-born layer VI neurons [65] (Fig 4A-C). No difference was 229 
observed between Kcc2+/+ and Kcc2– /– littermates in the thickness of the SSC layers (Cux1+, Kcc2–/–: -2.2 ± 230 
2.1% to Kcc2+/+; Ctip2+, Kcc2–/–:+2.9 ± 2.1% to Kcc2+/+; Tbr1+ Kcc2– /– : +3.4 ± 2.7% to Kcc2+/+; Fig 4A-C). Our 231 
data obtained in Kcc2lox/lox mice indicate preferential increase in cell death of late-migrating upper cortical 232 
neurons but not of neurons that had reached the upper cortical plate at E18.5 (Fig 3). Consistent with this, 233 
we did not observe any significant difference in the number of neurons expressing layer-specific markers 234 
within the cortical layers formed by E18.5 between the Kcc2+/+ and Kcc2–/– cortices (Cux1+, Kcc2–/–: -2.5 ± 235 
2.7% to Kcc2+/+; Ctip2+, Kcc2–/–: +1.6 ± 2.0% to Kcc2+/+; Tbr1+ Kcc2– /– : +2.1 ± 2.5% to Kcc2+/+; Fig 4A-C).  236 
We then investigated whether there is a preferential decrease in the number of upper cortical plate PNs 237 
that are still migrating at E18.5, and thus do not yet contribute to the existing cortical layers. We used IUE 238 
of EGFP at E14.5 to target upper cortical layer PN progenitors in Kcc2–/– embryos and their Kcc2+/– and 239 
Kcc2+/+ littermates. No difference was observed in the total number of EGFP+ neurons/ROI at E18.5 240 
between Kcc2+/+ and Kcc2+/– littermates (Kcc2+/+: 299.2 ± 27.6; n = 9 embryos; Kcc2+/–: 307.8 ± 45.37; n = 5 241 
embryos, p = 0.86; two-tailed t test; not illustrated) and these data were pooled. In line with the effect 242 
observed in Kcc2lox/lox embryos electroporated with EGFP+Cre (Fig 1A and B), we observed a statistically 243 
significant lower total number of EGFP+ neurons (Kcc2–/–: -21.8 ± 7.1%; Fig 4D and E) in slices from Kcc2–/– 244 
embryos compared to the pooled data from their Kcc2+/– and Kcc2+/+ littermate controls. Again, a 245 
statistically significant decrease in migrating EGFP+ neurons in Kcc2–/– embryos was restricted to the deep 246 
cortical regions, demarcated by the upper boundary of the Ctip2 immunosignal which labels layer V (Kcc2–/–247 
 : -41.4 ± 8.3% to Kcc2+/++Kcc2+/–; Fig 4F). No difference was observed in the number of migrating neurons 248 
above this zone (Kcc2–/–: -7.03 ± 8.3% to Kcc2+/++Kcc2+/–; Fig 4F). These data from the constitutive KCC2 249 
knockout line consolidate our observations made in the conditional knockout indicating that loss of KCC2 250 
does not decrease the number of cortical PNs within their target layers formed by E18.5. Moreover, they 251 
support the idea that the population of PNs affected by loss of KCC2 is delimited to neurons that are still 252 
migrating at E18.5.  253 
In summary, we found that the loss of intracellular signaling mediated by the CTD of KCC2 in late-born 254 
upper cortical PNs increases the likelihood for their elimination during the first of two major waves of 255 
neurodevelopmental apoptosis. Our data demonstrate that the canonical role of KCC2, K-Cl cotransport 256 
[20,21], is not at play in promoting the survival of neurons during the first wave of apoptosis. This is in line 257 
with overexpression studies in embryonic and early postnatal rats suggesting kinetic inactivation of KCC2 as 258 
a Cl- transporter in immature cortical projection neurons until around the time of birth [29,30,55]. 259 
Conditional deletion of KCC2 using Cre electroporation at E14.5 into Kcc2lox/lox embryos, targeting a 260 
subpopulation of late-born PNs, increased the fraction of apoptotic neurons at E16.5. Importantly, the 261 
number of neurons at E16.5 did not depend on KCC2 expression, indicating that the decrease in the 262 
number of neurons observed two days later is indeed due to enhanced cell-death and not to reduction in 263 
proliferation. Notably, our data indicate that constitutive genetic ablation of KCC2 expression does not 264 
perturb the lamination of the somatosensory cortex by E18.5, including no change in the number of 265 
neurons expressing layer-specific markers within the layers formed by this time in development. However, 266 
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we observed a selective loss of upper cortical PNs still migrating at E18.5 in both our constitutive and 267 
conditional KCC2 knockout models. Importantly, the number of neurons labeled at E14.5, which had 268 
reached the upper parts of the cortical plate at E18.5, was unaltered in both knockout models. Given that 269 
IUE at E14.5 targets progenitors that give rise to both layer IV and II/III PNs [48], it is probable that the 270 
neuronal population most susceptible to KCC2 deletion in these two mouse models belong to the upper 271 
cortical PNs that will form the superficial parts of the upper cortical plate, notably layer II/III PNs. Indeed, at 272 
the time of analysis, E18.5, the vast majority of layer II/III pyramidal neurons are still migrating in the deep 273 
parts of the cortical plate and in the IZ/SVZ [48], with little contribution yet to the nascent layer II/III. 274 
Strikingly, we found that expression of the missense KCC2 variant, KCC2R952H, which carries a point mutation 275 
in the  CTD  has been found in patients with febrile seizures [38], idiopathic generalized epilepsy [39], as 276 
well as autism and schizophrenia [40], was not only unable to rescue the late-born neurons migrating at 277 
E18.5, but also decreased the number of those that had by then reached the upper cortical plate. Thus, 278 
KCC2R952H may present as a pathological gain-of-function mutation, with capacity to promote excessive 279 
neuroapoptosis throughout the upper cortical plate PNs. Downregulation of KCC2 has been reported in 280 
human preterm infants with white matter damage [66], suggesting that an early loss of KCC2 may be 281 
related to cerebral palsy and encephalopathy of prematurity [67]. Perturbations in neurodevelopmental 282 
apoptosis are thought to contribute to early-onset epileptic encephalopathies [68,69]. An important 283 
implication of this study is that genetic variation in SLC12A5 or perinatal insults that result in KCC2 284 
downregulation may promote neurodevelopmental disorders by increasing cell death during early cortical 285 
development. At a broader scale, our findings stress the importance of the pleiotropic aspects of SLC12A5 286 
across ontogenesis. 287 
 288 
MATERIALS AND METHODS 289 
Animals 290 
The experiments were conducted according to the guidelines and with the approval of the National Animal 291 
Ethics Committee of Finland (Helsinki, Finland) and the local Animal Ethics Committee of the University of 292 
Helsinki (Helsinki, Finland). All animal procedures regarding the generation of Kcc2lox/lox mice followed the 293 
National Institute of Health guidelines on the use of animals (Bethesda, Maryland, USA) and were approved 294 
by the Vanderbilt University Institutional Animal Care and Use Committee (Nashville, Tennessee, USA). 295 
Both the heterozygous KCC2 mice used to generate Kcc2–/– (constitutive deletion model) [31,38,62] and 296 
Kcc2lox/lox (conditional deletion model, generated in this study) mice were housed in type II open 297 
polycarbonate cages with aspen wood bedding, within a conventional animal facility under a 12-h light-dark 298 
cycle and with food and water available ad libitum. The cages were enriched with wooden and cardboard 299 
play tunnels, and polycarbonate retreats. Mouse pups (P15-17) were kept together with the dams until 300 
used. E16.5-18.5 mouse embryos and P15-17 pups of either sex were used for analysis. 301 
Generation of the Kcc2lox/lox line  302 
Embryonic stem cells derived from 129/SvEvTac mice were transfected with a construct targeting the 303 
Slc12a5 gene, encoding KCC2 protein. The construct consists of a 7.6 kb genomic DNA fragment as the long 304 
arm of recombination, followed by a loxP site, the neomycin resistance gene cassette, a second loxP site, 305 
740 bp of genomic DNA containing exon-5, a third loxP site and a 1.1 kb short arm of recombination (Fig 306 
EV2A). Exon-5 of Slc12a5 encodes the end of the second transmembrane domain (TM2) and a portion of 307 
the intracellular loop between TM2-TM3. Deletion of this exon results in a preterm stop codon and 308 
complete KCC2 knockout. Three hundred and sixty neomycin-resistant colonies were picked and analyzed 309 
by Southern blot. Twelve clones were identified as having successfully recombined, and two of them were 310 
injected into C57BL6 blastocysts, generating chimeric males and germline transmission. Mice carrying the 311 
allele with all three loxP sites in the Slc12a5 gene were crossed to E2a-Cre deleter line to randomly produce 312 
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mice with a reduction from three loxP to two loxP sites. PCR genotyping identified a mouse having lost the 313 
neomycin resistance gene cassette but conserved the exon. One additional mating with E2a-Cre mice 314 
verified the functionality of the remaining two loxP sites (reduction to one loxP with loss of the exon) 315 
flanking exon-5 (Fig EV2B).  316 
To confirm that exon-5 can be efficiently deleted after transient overexpression of Cre recombinase, we 317 
used a PCR strategy in Kcc2lox/lox cortical primary neurons. A set of primers was designed to produce a PCR 318 
product of ~180 bp in a case of successful recombination (and exon-5 deletion), and ~280 bp PCR product 319 
for the intact KCC2-flox allele. Cortical neuronal cultures were derived from E17.5 Kcc2lox/lox mouse embryos 320 
and maintained in 4-well plates in Neurobasal medium supplemented with B27 and penicillin/streptomycin 321 
mix for 8 days in vitro (DIV). DIV 8 cultures were transfected (0.5 µg per well) with either Cre-expression 322 
construct, or with an empty vector using Lipofectamine2000 (Thermo Fisher Scientific) according to the 323 
manufacturer’s protocol. Two days later, the cultures were lysed, and genomic DNA was purified using DNA 324 
extraction kit Blood & Cell Culture DNA Mini Kit (QIAGEN). GoTaq® G2 Ready-to-Use Master Mix was used 325 
to amplify the purified genomic DNA (~100 ng) with the following primers: NB3 (forward): 5’-326 
TTACACAAGTACTGCGGTCCATTG-3’, NB4 (reverse-1): 5’-GCCTCAAGGCTATGTGTAAAGACTCA-3’, NB14 327 
(reverse-2): 5’-GACACCATCATCTGCCTCCTTCCC-3’. PCR cycling conditions were: 95 °C 2 min; 40 cycles: 95 °C 328 
25 sec, 58 °C 25 sec, 72 °C 45 sec; 72 °C 5 min. PCR reactions were run on a 2.5% agarose gel. 329 
In utero electroporation 330 
In utero electroporation of timed-pregnant mice with E14.5 embryos was done as before [38], with the 331 
following modifications: timed‐pregnant mice were anesthetized with isoflurane (4% induction in narcosis 332 
box, 2% during surgery at operation platform). The animals were then injected subcutaneously with the 333 
analgesic (0.1 ml, Buprenorphine, 0.05 mg/kg). A small incision was made along the abdomen, the 334 
peritoneal cavity was surgically opened, and the uterine horns were exposed. Embryos were injected 335 
intraventricularly with 1.25 μl of a solution containing Fast Green (Sigma) in sterile PBS and plasmid DNA (2-336 
3 µg/µl). The embryos were subsequently electroporated with forceps-type electrodes (CUY650P5, Sonidel 337 
Limited) placed at 0° from the horizontal plane of the brain [49–51] with five 50 ms pulses of 45 V at 100 ms 338 
intervals delivered with a square-wave generator (CUY21vivo SC, Sonidel Limited). After the surgery, mice 339 
were injected subcutaneously with the analgesic for two days (0.15 ml, Carprofen, 5mg/kg). Mice were 340 
allowed to recover, and embryos were harvested either 48 h (E16.5) or 96 h (E18.5) post-electroporation, 341 
or at P15-17. 342 
Expression vectors for in utero electroporation 343 
All of the plasmid constructs bearing a modified chicken β-actin promoter with a cytomegalovirus 344 
immediate early enhancer (CAG) have been described and used previously for in utero electroporation and 345 
transfection: Cre-recombinase (Cre; a gift from Prof. Connie Cepko, Addgene plasmid # 13775) [70], full-346 
length KCC2 (KCC2FL), N-terminally truncated KCC2 (KCC2ΔNTD), C-terminal domain of KCC2 (KCC2CTD) [31,34], 347 
a KCC2 variant with an arginine-to-histidine substitution at position 952 of KCC2b (KCC2R952H) [38], a cofilin 348 
variant with a serine-to-arginine substitution at position 3 (cofilinS3A, a kind gift from Prof. Michael 349 
Frotscher) [59], and an empty expression construct (pCAGEN, a gift from Prof. Connie Cepko, Addgene 350 
plasmid # 11160) [71].  351 
pCAG-EGFP [34,38] or pCAG-mRFP (a gift from Prof. Joseph LoTurco, Addgene plasmid #28311) [72] 352 
constructs were co-injected to fluorescently label the electroporated neurons, except in experiments with 353 
pCAG-cofilinS3A-EGFP. To reduce the factor of differences in the exact postconceptional age, in part of the 354 
electroporation experiments, every second embryo within the same uterus received injection of one of two 355 
different KCC2 variant plasmid constructs, discerned by co-injection of either pCAG-EGFP or pCAG-mRFP. 356 
No differences in neuronal numbers or their distribution patterns were associated with the choice of the 357 
fluorescent reporter used (see Results).  358 
For the experiments using Kcc2lox/lox animals, the total DNA concentration was kept constant at 3 µg/µl, 359 
of which the final concentration of the Cre plasmid in the mixture was 2 µg/µl, EGFP 0.3 µg/µl, and KCC2 360 
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and cofilin constructs 0.7 µg/µl. pCAGEN was added ad 3 µg/ml, where appropriate, to keep the total DNA 361 
concentration constant. For experiments done in Kcc2+/+ and Kcc2–/– embryos, the total DNA concentration 362 
in the IUE mixture was kept at 2 µg/µl, of which the EGFP plasmid constituted 0.3 µg/µl and pCAGEN 1.7 363 
µg/µl.  364 
Assessment of the efficacy of KCC2-mediated Cl- extrusion in layer 2/3 projection neurons 365 
Acute 400-µm coronal neocortical slices were prepared from in utero electroporated Kcc2lox/lox mice, using 366 
methods described before [34,44]. To measure KCC2-mediated Cl- extrusion, we used our standard whole-367 
cell recording assay where a somatic Cl- load (19 mM) is imposed on the neuronal soma via the recording 368 
whole-cell patch pipette [44]. Whole-cell patch-clamp recordings and confocal microscopy were performed 369 
as before [44] from EGFP-positive upper cortical layer projection neurons from slices of P15-17 mice (n = 6 370 
animals from 4 different litters) co-electroporated in utero with plasmids bearing constructs encoding for 371 
EGFP and Cre. Neighboring non-transfected (EGFP-negative) neurons served as internal controls. One to 372 
four neurons per group were recorded from each slice and their averaged values used for statistical 373 
analysis. Locally applied DPNI-caged GABA (1 mM Tocris) was used to elicit photolysis-induced (375 nm UV-374 
laser, 10 ms) GABAAR-mediated currents at the soma or 50 µm away at the apical dendrite [44]. All 375 
recordings were performed in the presence of 10 µM bumetanide (Tocris), 0.5 µM TTX (Abcam), 20 µM D-376 
AP5 (Tocris), 10 µM CNQX (Abcam) and 1 µM CGP 55845 (Abcam) in the standard extracellular solution 377 
[44,73]. Membrane potential values were corrected for series resistance effect and for a calculated liquid 378 
junction potential of 14 mV.  379 
Tissue processing and immunohistochemistry 380 
E18.5 mouse brains were briefly fixed by immersion in 4% PFA in PBS, cryoprotected overnight in 30% 381 
sucrose, frozen in Tissue-Tek O.C.T. Compound (Sakura FineTek), and cut into 40-µm coronal free-floating 382 
slices on a CM1900 cryostat (Leica). For cleaved-Caspase-3 staining, the E16.5 brains were cut into 16-µm 383 
coronal slices, and post-fixed with 1% PFA in PBS at room temperature prior to staining. Brain slices were 384 
washed three times for 10 min in PBS (pH 7.4) and blocked in 3% BSA, 0.3% Triton-X, and 10% goat serum in 385 
PBS for 2 hours at room temperature. Primary antibodies were incubated overnight at +4°C; sections were 386 
then washed and incubated in secondary antibodies in modified blocker solution (1% BSA, 0.3% Triton-X, 387 
10% goat serum in PBS) for 2 hours at RT. The sections were then washed in PBS; the nuclei were stained 388 
with 4, 6-diamidino-2-phenylindole (DAPI, 2.5 µg/µl in PBS) for 10 min. The sections were mounted on glass 389 
slides with FluoroMountG (Thermo Fisher) and stored at +4°C until imaging. Antibodies used in this study 390 
were: cleaved Caspase-3 (#9661, Cell Signalling, 1:400), Cux1 (sc-13024, Santa Cruz, 1:100), Ctip2 (ab18465, 391 
Abcam, 1:250), Tbr1 (AB10554, Millipore, 1:1000), KCC2 (07-432, Millipore, 1:1000), Cre (MB3127, 392 
Millipore, 1:1000).  393 
TUNEL labeling of apoptotic neurons 394 
E16.5 mouse brains were briefly fixed by immersion in 4% PFA in PBS, cryoprotected overnight in 30% 395 
sucrose, frozen in Tissue-Tek O.C.T. Compound (Sakura FineTek), cut into 16-µm coronal slices on a CM1900 396 
cryostat (Leica), mounted on positively charged glass slides (Super-FrostPlus; VWR International), and 397 
stored at −80°C. To assess the number of apoptotic neurons, we used the ApopTag Red In Situ Apoptosis 398 
Detection Kit (Millipore) following the manufacturer’s instructions for tissue cryosections. Briefly, brain 399 
slices were post-fixed with 1% PFA in PBS at room temperature followed by treatment with Ethanol: Acetic 400 
acid (2:1) at -20°C. After fixation and washes, working strength TdT enzyme in Reaction Buffer was added to 401 
the sections and incubated at +37°C. The reaction was stopped with the Stop/Wash Buffer, and DNA 402 
fragments were stained using anti-digoxigenin Rhodamine in Blocker at room temperature. Nuclei were 403 
stained with 4, 6-diamidino-2-phenylindole (DAPI, 1 µg/µl in PBS). The sections were mounted on glass 404 
slides with FluoromountG (Thermo Fisher) and stored at +4°C until imaging. 405 
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Image acquisition and analysis 406 
Images were collected with LSM confocal microscope equipped with LD LCI Plan-Apochromat 25x/0.8 Imm 407 
Corr objective, Axio Imager 2 light microscope equipped with ApoTome with 25x and 40x/oil immersion 408 
objectives, and Axio Imager M1 with 10x objective (all from Zeiss). Images of E16.5 brains used for TUNEL 409 
and E18.5 brains used for KCC2 IHC staining are presented as maximum intensity projections of 10 optical 410 
sections taken at 0.5 µm intervals. Representative images of E18.5 sections from Kcc2lox/lox embryos co-411 
electroporated in utero at E14.5 with constructs expressing EGFP or mRFP are indicated by pseudo-color in 412 
green. All images were analyzed using FIJI [74]. 413 
Analysis of cortical layering 414 
For the analysis of cortical lamination in E18.5 Kcc2–/– embryos and their wildtype littermates, we analyzed 415 
the cortical plate at the level of the nascent SSC at the same rostro-caudal level for each brain 416 
(approximately three mm from bregma, [75], the junction of the lateral ventricle and the caudo-putamen). 417 
The developing cortical plate was divided into three regions delineated by different layer-specific 418 
antibodies: Cux1 to mark the superficial, late-born neurons in layers II-IV [63], Ctip2 to mark the layer V 419 
neurons [64], and Tbr1 to mark layer VI neurons [65]. Cortical layer thickness and the number of neurons 420 
was assessed in a common boxed region of 600*400 µm and analyzed in FIJI [74]. After background 421 
subtraction, the layer thickness was measured perpendicular to the surface of the cortex. To quantify the 422 
number of neurons within each neocortical layer, the images of brain slices stained against Cux1, Ctip2, or 423 
Tbr1 were thresholded, and the command Analyze particles was used to quantify and create a mask 424 
containing ROIs of the neurons expressing the layer-specific markers. In the analysis of the total thickness 425 
of the cortical plate and the number of neurons expressing layer-specific markers within individual cortical 426 
layers, data were normalized to WT corresponding controls. 427 
Quantification of neuronal numbers 428 
To quantify the total number of neurons electroporated in utero, the number of fluorescent cells was 429 
calculated in the electroporated area in a common boxed region of 850*650 µm in a semi-automated way 430 
using FIJI [74]. The background was subtracted from the neurons expressing either EGFP or mRFP, the 431 
image was thresholded, and the command Analyze particles was used to create a mask containing ROIs of 432 
neurons. The neurons that were omitted by the automatic procedure were added manually. For 433 
quantification of the number of neurons that migrated to the upper cortical layers, the cortical plate was 434 
divided into upper (layers II-VI) and lower (layers V and VI, as well as the area below the cortical plate 435 
comprising both IZ and SVZ) sub regions using the Ctip2-immunostaining of layer V neurons at the same 436 
rostro-caudal level for each brain (approximately 3mm from bregma, [75]).  437 
The percentage of the EGFP+ neuronal population undergoing apoptosis was quantified using activated 438 
caspase 3 (Cas-3) staining or TUNEL in slices from E16.5 Kcc2lox/lox embryos electroporated with EGFP±Cre. 439 
The background was subtracted from the Cas3+ neurons or TUNEL+ nuclei, the image was thresholded, and 440 
the command Analyze particles was used to create a mask containing the labeled neurons. The neurons 441 
that showed showed Cas-3 staining or DNA fragmentation were marked as apoptotic (Cas-3+, TUNEL+) and 442 
quantified manually.  443 
Slc12a5 mRNA expression 444 
The online source DeCoN (Developing Cortical Neuron Transcriptome Resource, 445 
http://decon.fas.harvard.edu/pyramidal/gene/Slc12a5) was used to compare expression levels of the 446 
Slc12a5 gene (encoding KCC2) at the time points of interest (Data ref: [46]). KCC2 expression datasets were 447 
derived from isoform-deconvolution based differential RNA-sequencing of sorted cellular populations 448 
corresponding to three neuronal subclasses at specified time points during corticogenesis (E15.5, E16.5, 449 
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E18.5, and P1) [45]. Two biological replicates were used for each neuronal subtype and developmental time 450 
point (one litter of six to ten CD1 mouse embryos or pups was used as one biological replicate). 451 
Statistics 452 
Statistical analyses were performed in Prism 8 (GraphPad Software). Normality was tested using 453 
Kolmogorov-Smirnov test for each distribution, and significance level α was set to 5% for all tests. Normally 454 
distributed data were analyzed using one-tailed or two-tailed Student's t-test. For non-Gaussian 455 
distributions, the Mann-Whitney U test was used. For multiple comparisons, statistical significance was 456 
determined using one-way ANOVA with Holm-Sidak's post-hoc test for normally distributed data, otherwise 457 
the Kruskal-Wallis test with Dunn's post hoc was used. For experiments with internal control within the 458 
same slice, ANOVA with repeated measures followed by Bonferroni's post hoc was used. The statistical test 459 
used for each experiment is indicated in the Figure legends. Equality of group variance was estimated using 460 
the Brown-Forsythe test. No significant difference in variance was observed between the groups that were 461 
statistically compared, except for the Fig 4A, B and C panels depicting the number of neurons in cortical 462 
layers labeled with layer-specific antibodies. In this case we detected a significant difference in the variance 463 
of the analyzed groups (p = 0.008, Brown-Forsythe test). A non-parametric test (Kruskal-Wallis test with 464 
Dunn's post hoc) was used in this case. No randomization was done in this study. Due to the mechanistic 465 
and exploratory nature of this work, no statistical power analysis was used to guide sample-size estimation. 466 
Experiments on in utero electroporated animals were performed and analyzed in a blinded manner 467 
concerning the genetic construct used, whereas experiments on Kcc2+/+ and Kcc2–/–embryos were analyzed 468 
in a blinded fashion with respect to the genotype of the embryos. Based on our previous experience, for in 469 
utero electroporation experiments 5-13 animals from 3-5 different litters were used per experimental 470 
group. To obtain the mean number of neurons per embryo 1-3 slices were analyzed. Slices containing less 471 
than 100 electroporated neurons/ROI were excluded from statistical analysis. For electrophysiological 472 
experiments, 1-4 neurons per slice were analyzed. The sample size of each experimental group is stated in 473 
the Figure legends. Data are presented as mean ± S.E.M., except for Fig EV1 where data are presented as 474 
mean ± 95% CI. 475 
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FIG CAPTIONS  686 
Fig 1. Genetic loss of KCC2 promotes apoptosis of embryonic neocortical projection neurons in vivo 687 
A Representative images of E18.5 coronal cortical sections from Kcc2lox/lox embryos electroporated in 688 
utero at E14.5 with plasmids encoding EGFP, EGFP+Cre (Cre) or EGFP+Cre+KCC2FL (Cre+KCC2FL). DAPI 689 
staining (blue) marks cell nuclei. UCP, upper cortical plate; LCP, lower cortical plate; Sp, subplate; IZ, 690 
intermediate zone. Scale bar: 50 µm. 691 
B Quantification of the number of EGFP+ neurons/ROI from embryos electroporated with constructs in 692 
(A). Statistical significance was determined using one-way ANOVA with Holm-Sidak’s post hoc test, **P < 693 
0.01. Data are presented as mean ± S.E.M., n (EGFP) = 8 embryos; n (Cre) = 8 embryos; n (Cre+KCC2FL) = 694 
13 embryos. 695 
C Representative image of cleaved Caspase 3 (Cas-3, upper panel) and TUNEL (lower panel) staining in 696 
coronal sections from Kcc2lox/lox cortex at E16.5 electroporated with EGFP or EGFP+Cre are shown. 697 
Arrowheads point to neurons expressing Cas-3 (upper panel) and TUNEL (lower panel). DAPI staining 698 
(blue) marks cell nuclei. CP, cortical plate; VZ, ventricular zone; SVZ, subventricular zone; Sp, subplate; IZ, 699 
intermediate zone. Large scale bar: 50 µm, small scale bar: 20 µm.  700 
D Quantification of the percentage of EGFP+ neurons expressing apoptotic markers at E16.5 from embryos 701 
electroporated with EGFP ± Cre. Statistical significance was determined using Mann-Whitney U test (Cas-702 
3); and two-tailed t test (TUNEL), ***P < 0.001. Data are presented as mean ± S.E.M., n (-Cre) = 6 703 
embryos; n (+Cre) = 6 embryos.  704 
E The number of EGFP+Cre neurons as a percentage of neurons expressing EGFP alone. Statistical 705 
significance was determined using a two-tailed Student’s t test. Data are presented as mean ± S.E.M., n = 706 
6 embryos. 707 
 708 
Fig 2. Ion transport-independent actions of KCC2 CTD promote the survival of migrating projection 709 
neurons 710 
A Top: Representative images of E18.5 coronal cortical brain sections from Kcc2lox/lox embryos 711 
electroporated in utero at E14.5 together with plasmid constructs encoding Cre, a fluorescent marker 712 
(EGFP or mRFP, both pseudo-colored in green) and one of the following constructs: KCC2ΔNTD, KCC2CTD, 713 
KCC2R952H, or cofilinS3A. DAPI staining (blue) marks cell nuclei. UCP, upper cortical plate; LCP, lower cortical 714 
plate; Sp, subplate; IZ, intermediate zone. Scale bar: 50 µm. Bottom: schematic representation of the 715 
KCC2 constructs.  716 
B Quantification of the number of transfected neurons/ROI from embryos electroporated with constructs 717 
in (A). The mean number of transfected neurons from embryos electroporated with Cre+KCC2FL taken 718 
from Fig 1B shown as dotted line. Statistical significance was determined using one-way ANOVA with 719 
Holm-Sidak's post hoc test, **P < 0.01 to Cre+KCC2FL. Data are presented as mean ± S.E.M., n (KCC2ΔNTD) = 720 
7 embryos; n (Cre+KCC2CTD) = 9 embryos; n (Cre+KCC2R952H) = 9 embryos; n (Cre+cofilinS3A) = 8 embryos.  721 
 722 
Fig 3. Cell death mediated by KCC2 deletion differentially affects upper cortical PNs migrating in deep- 723 
vs. superficial-layers at E18.5 724 
A Representative image of E18.5 coronal cortical sections stained for layer V marker Ctip2 (red) from 725 
Kcc2lox/lox embryos electroporated in utero at E14.5 with plasmid constructs encoding EGFP or EGFP+Cre 726 
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(Cre). Upper boundary of layer V indicted with dotted line. EGFP signal is shown as green pseudocolor. 727 
DAPI staining (blue) marks cell nuclei. Sp, subplate; IZ, intermediate zone. Scale bar = 50 µm.  728 
B Number of EGFP+Cre neurons migrating above (II-IV) and below (V-VI/IZ-SVZ) the upper border of layer 729 
V normalized to respective data from embryos electroporated with EGFP alone. Statistical significance 730 
was determined using one-way ANOVA with Holm-Sidak’s post hoc test, ***P < 0.001 to EGFP. Data are 731 
presented as mean ± S.E.M., n (EGFP+Cre) = 8 embryos; n (EGFP) = 8 embryos. 732 
C Representative image of E18.5 coronal brain sections stained for layer V marker Ctip2 (red) from 733 
Kcc2lox/lox embryos electroporated in utero at E14.5 with plasmid constructs encoding mRFP or mRFP+Cre 734 
(Cre). Upper boundary of layer V indicted with dotted line. Sp, subplate; IZ, intermediate zone. Scale bar = 735 
50 µm. mRFP signal is shown as green pseudocolor. DAPI staining (blue) marks cell nuclei. 736 
D Number of mRFP+Cre neurons migrating above (II-IV) and below (V-VI/IZ-SVZ) the upper border of layer 737 
V normalized to respective data from embryos electroporated with mRFP alone. Statistical significance 738 
was determined using one-way ANOVA with Holm-Sidak’s post hoc test, ***P < 0.001 to mRFP. Data are 739 
presented as mean ± S.E.M., n (mRFP+Cre) = 5 embryos; n (mRFP) = 5 embryos. 740 
E Representative image of E18.5 coronal cortical sections stained for layer V marker Ctip2 (red) from 741 
Kcc2lox/lox embryos co-electroporated in utero at E14.5 with plasmids encoding a fluorescent marker 742 
(green) together and Cre+KCC2FL, Cre+KCC2CTD, or Cre+KCC2R952H. DAPI staining (blue) marks cell nuclei. 743 
Upper boundary of layer V indicted with dotted line. Sp, subplate; IZ, intermediate zone. Scale bar = 50 744 
µm. 745 
F Number of transfected neurons migrating above (II-IV, left) and below (V-VI/IZ-SVZ, right) the upper 746 
border of layer V in embryos electroporated with constructs in (E) normalized to respective data from 747 
embryos electroporated with Cre. Statistical significance was determined using one-way ANOVA with 748 
Holm-Sidak’s post hoc test, *P < 0.05, **P < 0.01, ***P < 0.001 to Cre. Data are presented as mean ± 749 
S.E.M., n (Cre+KCC2FL) = 13 embryos; n (Cre+KCC2CTD) = 9 embryos; n (Cre+KCC2R952H) = 9 embryos. 750 
 751 
Fig 4. Constitutive ablation of KCC2 does not alter cortical lamination but increases cell death of deep-752 
layer migrating upper cortical layer PNs at E18.5  753 
A, B, C The layer thickness and neuronal number within each layer was assessed using layer-specific 754 
markers in Kcc2–/–and Kcc2+/+ embryos at E18.5. Cux1 was used to label layers II-IV (A), Ctip2 to label layer 755 
V (B), and Tbr1 to label layer VI (C). Dashed white lines in the representative images in (A-C) indicate 756 
upper and lower layer boundaries. Sp, subplate. Statistical significance was determined using Kruskal-757 
Wallis test with Dunn’s post hoc (neuronal numbers) and one-way ANOVA with Holm-Sidak's post hoc 758 
(layer thickness). Data are presented as mean ± S.E.M., n = 11 embryos for both genotypes. Scale bar = 50 759 
µm. 760 
D Representative image of E18.5 coronal cortical sections stained for layer V marker Ctip2 (red) in Kcc2–/– 761 
and Kcc2+/+ embryos electroporated in utero at E14.5 with a plasmid encoding EGFP (green). DAPI staining 762 
(blue) marks cell nuclei. Upper boundary of layer V indicted with dotted line. Sp, subplate; IZ, 763 
intermediate zone. Scale bar = 50 µm. 764 
E Neurons from the brain sections in (D) were quantified and the total number of EGFP+ neurons in the 765 
Kcc2–/– sections is presented as a percentage of pooled Kcc2+/+ and Kcc2+/– values. Statistical significance 766 
was determined using one-tailed Student’s t test, *P < 0.05. Data are presented as mean ± S.E.M., n 767 
(Kcc2+/+ + Kcc2+/–) = 14 embryos; n (Kcc2–/–) = 9 embryos.  768 
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F Number of EGFP+ neurons in Kcc2–/– embryos migrating above (II-IV) and below (V-VI/IZ-SVZ) the upper 769 
border of layer V normalized to respective pooled data from Kcc2+/+ and Kcc2+/– embryos. Statistical 770 
significance was determined using one-way ANOVA with Holm-Sidak’s post hoc test, **P < 0.01 to Kcc2+/+ 771 
+ Kcc2+/–. Data are presented as mean ± S.E.M., n (Kcc2+/+ + Kcc2+/–) = 14 embryos; n (Kcc2–/–) = 9 embryos.  772 
 773 
Fig EV1. KCC2 mRNA expression in embryonic mouse cortical projection neurons 774 
Developmental expression of the mRNA transcripts encoding KCC2 (Slc12a5) measured by RNAseq in the 775 
embryonic mouse neocortical projection neurons at E15.5, E16.5, E18.5 and P1 in the purified callosal 776 
projection neurons (CPN), subcortical projection neurons (ScPN), and corticothalamic/subplate neurons 777 
(CthPN) (http://decon.fas.harvard.edu/pyramidal/gene/Slc12a5 ). Data are presented as mean ± 95% CI. 778 
n (biological replicates) = 2 mouse litters/age point; n (technical replicates) = 6-10 animals/litter. FPKM, 779 
Fragments Per Kilobase of transcript per Million mapped reads. Dotted line indicates detectable 780 
expression level (FPKM ≥ 2; [37]).  781 
Fig EV2. Cre-lox strategy to delete Kcc2 in vitro and in vivo 782 
A Schematic representation of the wild-type Kcc2 allele (exons 2 to 7) and a targeting vector used to 783 
generate Kcc2lox/lox mouse line. Exons are depicted as yellow rectangles and loxP sites as red triangles. A 784 
neomycin cassette surrounded by two loxP sites inserted into intron 4. A thymidine kinase cassette (TK) 785 
was used as a negative selection marker. The thymidine kinase and neomycin cassettes both were 786 
expressed under the control of the phosphoglycerate kinase (PGK) promoter. 787 
B Functionality of the loxP sites in the Kcc2lox/lox mice was verified by crossing these mice with E2a-CRE 788 
deleter mice. PCR analysis revealed only one amplicon, which corresponds to the recombinant allele. 789 
C Kcc2 allele can be rapidly inactivated by transient (48 hours) overexpression of Cre-recombinase in 790 
dissociated neuronal cultures plated from Kcc2lox/lox embryos. PCR detects ~180 bp recombinant amplicon 791 
corresponding to the inactivated Kcc2 allele in the cultures transfected with the Cre-recombinase (+Cre), 792 
but not in the control (-Cre) cultures. Since the standard Lipofectamin2000 transfection protocol results in 793 
less than 1% of transfected neurons in dissociated neuronal cultures, PCR product ~300 bp corresponding 794 
to the intact Kcc2 allele in non-transfected neurons is also present on the agarose gel. 795 
D Representative images of E18.5 coronal brain sections prepared from Kcc2lox/lox embryos co-796 
electroporated in utero at E14.5 with constructs encoding EGFP (green, upper panel) and Cre-797 
recombinase together with EGFP (lower panel) and subsequently analyzed at 18.5 by IHC with anti-KCC2 798 
antibody (red). DAPI staining (blue) marks cell nuclei. Arrowheads point to neurons expressing EGFP. UCP, 799 
upper cortical plate; LCP, lower cortical plate; Sp, subplate; IZ, intermediate zone. Scale bar = 50 µm. 800 
E Quantification of the number of KCC2+ neurons as a percentage of EGFP+ neurons from embryos 801 
electroporated with EGFP alone (-Cre) or with EGFP+Cre (+Cre). Statistical significance was determined 802 
using Mann-Whitney U test, ***P < 0.001. Data are presented as mean ± S.E.M., n (-Cre) = 14 embryos; n 803 
(+Cre) = 8 embryos.  804 
F Representative images of E18.5 coronal brain sections prepared from Kcc2lox/lox embryos, co-805 
electroporated in utero at E14.5 with Cre-recombinase and EGFP (green) expression constructs, and 806 
subsequently analyzed by IHC with anti-Cre antibody (red) at E18.5. DAPI staining (blue) marks cell nuclei. 807 
Arrowheads point to neurons expressing EGFP. UCP, upper cortical plate; LCP, lower cortical plate; Sp, 808 
subplate; Scale bar = 50 µm. 809 
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G Quantification of Cre+ neurons as a percentage of EGFP+ neurons in E18.5 coronal brain sections of 810 
Kcc2lox/lox embryos (n = 11) co-electroporated in utero at E14.5 with Cre-recombinase and EGFP expression 811 
constructs. Data are presented as mean ± S.E.M. 812 
 813 
Fig EV3. In utero co-electroporation of mRFP and Cre results in loss of embryonic neocortical PNs in vivo 814 
A Representative images of E18.5 coronal cortical sections from Kcc2lox/lox embryos electroporated in 815 
utero at E14.5 with plasmids encoding mRFP or mRFP+Cre (Cre). DAPI staining (blue) marks cell nuclei. 816 
UCP, upper cortical plate; LCP, lower cortical plate; Sp, subplate; IZ, intermediate zone. Scale bar: 50 µm. 817 
B Quantification of the number of mRFP+ neurons/ROI from embryos electroporated with constructs in 818 
(A). Statistical significance was determined using two-tailed Student’s t-test, *P < 0.05. Data are presented 819 
as mean ± S.E.M., n (mRFP) = 5 embryos; n (Cre) = 5 embryos. 820 
Fig EV4: Abolished Cl- extrusion capacity of upper cortical PNs following conditional deletion of KCC2 in 821 
Kcc2lox/lox mice  822 
A Sample recordings of GABA uncaging–induced currents (IGABA) in neighboring postnatal day (P) 15-17 823 
projection neurons EGFP-positive Cre-transfected (Kcc2lox/lox(+Cre)) and GFP-negative non-transfected 824 
(Kcc2lox/lox(-Cre)) neurons at the soma (bottom traces, black circles) and at a distance 50 µm away from soma 825 
along the apical dendrite (top traces, grey circles). Horizontal bar indicates a 10-ms uncaging flash of UV 826 
light.  827 
B Mean somatic and apical dendritic EGABA values in neighboring EGFP-positive Cre-transfected 828 
(Kcc2lox/lox(+Cre)) and EGFP-negative non-transfected (Kcc2lox/lox(-Cre)) neurons. [GHK]: theoretical EGABA level 829 
denoted by the dotted line predicted by the Goldman-Hodgkin-Katz voltage equation under the present 830 
experimental conditions in the absence of active anion regulation. Statistical significance was determined 831 
using repeated measures one-way ANOVA with Bonferroni’s post hoc test, **P < 0.01, ***P < 0.001. Data 832 
are presented as mean ± S.E.M., n = 10 slices from 6 embryos, 1-4 neurons recorded per group in each 833 
slice. 834 
C, D, E Resting membrane potential (Vm) (C), input resistance (Rin) (D) and membrane capacitance (Cm) (E) 835 
from neurons recorded in (B). Statistical significance was determined using paired two-tailed Student’s t 836 
test. Data are presented as mean ± S.E.M., n = 10 slices from 6 embryos, 1-4 neurons recorded per group 837 
in each slice. 838 








